OptiMedica Corp. announced the debut of its new photocoagulator (PASCAL Slim Line) here at the World Ophthalmology Congress. The system provides physicians and their patients with the significant benefits of pattern-scanning in a new, compact design.
OptiMedica Corp. announced the debut of its new photocoagulator (PASCAL Slim Line) here at the World Ophthalmology Congress.The system provides physicians and their patients with the significant benefits of pattern-scanning in a new, compactdesign.
Representing a leap forward from single-spot green laser photocoagulation, the company's proprietary, semi-automated patterngeneration allows for the rapid delivery of 532 nm laser pulses in a predetermined sequence. Indicated for a variety ofretinal diseases-including diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusivedisease-the technique enables physicians to improve their control of the precision, safety, and efficiency of thephotocoagulation procedure, while optimizing patient comfort and convenience, according to OptiMedica.
"The launch of the [photocoagulator] represents OptiMedica's unwavering commitment to meeting customer needs," said Mark J.Forchette, president and chief executive officer of OptiMedica. "We are thrilled to report that early users have alreadygiven us rave reviews for [its] performance and sleek design, which together are aimed at addressing the unique clinical andeconomic challenges of the office-based practice."
The new photocoagulator is currently available in the United States and Japan and will be rolled out worldwide over thefourth quarter of 2008.